Proviva Therapeutics

Private

ShanghaiHealthcare & Life Scienceshttps://provivatx.cn

Last Round

Series A

Feb 1, 2023

Total Funding Raised

$48M

Company Overview

Proviva Therapeutics is a biotechnology company that develops a pharmaceutical technology platform intended for anti-tumor immunity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

cancer immunotherapyimmuno-oncologyprodrug technologycytokine prodrugfusion proteintumor microenvironment activationcytokine therapypro-cytokineI-Ocheckpoint inhibitorPD-1/IL-2 fusion proteinclinical stage biotecheffector cell activationbiopharmaceuticals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proviva Therapeutics Comparables

Compare Proviva Therapeutics with similar companies based on industry and business-model similarity.

Proviva Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
AskGene Pharma	83%
Asher Biotherapeutics	82%
Aulos Bioscience	81%

View all Comparables

Proviva Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Feb 1, 2023
Series A Extension	Dec 1, 2022

View all Funding Rounds

Proviva Therapeutics Investors

Notable investors and investment history

Proviva Therapeutics investors
Investor	Rounds
OrbiMed	Series A Extension
Ennovation Ventures	Series A
HongShan Capital Group (HSG)	Series A Extension

View all Investors

Proviva Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Proviva Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Proviva Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Year Founded2019

Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?